首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

2075347

雌激素拮抗劑市場：依產品類型、應用、通路和地區分類

Estrogen Blockers Market, By Product Type, By Application, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，雌激素拮抗劑市場規模將達到 181.8 億美元，到 2033 年將達到 286.3 億美元。預計 2026 年至 2033 年的複合年成長率將達到 6.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	181.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.70%	2033年市場規模預測：	286.3億美元

雌激素阻斷劑是變性男性（女變男）在荷爾蒙補充療法（HRT）中用來抑制體內雌激素作用的藥物。它們也有助於促進男性第二性徵的發展。雌激素阻斷劑有多種類型，其作用各不相同。

雌激素阻斷劑可以口服（片劑）或注射。它們通常作為更全面的荷爾蒙替代療法（HRT）治療方案的一部分，患者通常耐受性良好。大多數情況下，服用這些藥物無需住院，通常可以在家中服用。

市場動態

雌激素阻斷劑廣泛用於治療多囊性卵巢症候群（PCOS）、子宮卵巢異位症和乳癌等荷爾蒙相關疾病。隨著這些疾病在全球範圍內的發病率不斷上升，對雌激素阻斷劑的需求也在成長，從而推動了市場擴張。

例如，根據世界衛生組織（世衛組織）2023年6月28日發布的報告，卵巢症候群（PCOS）是一個重要的公共衛生問題，被認為是影響育齡女性最常見的荷爾蒙失調疾病之一。據估計，每年約有8%至13%的育齡女性患有此病，而高達70%的病例未被診斷出來。

另一方面，與其他藥物一樣，雌激素阻斷劑也存在潛在風險和副作用。常見的副作用包括潮熱、情緒波動、關節不適和膽固醇水平升高。在某些情況下，長期使用雌激素阻斷劑可能會增加心血管疾病和骨質流失的風險。對安全性和潛在副作用的擔憂可能會影響患者對雌激素阻斷劑的依從性和接受度。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球雌激素拮抗劑市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球雌激素阻斷劑市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球雌激素阻斷劑市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Pfizer Inc.
Novartis AG
AstraZeneca PLC
Eli Lilly and Company
Merck & Co., Inc.
Bristol Myers Squibb Company
Sanofi SA
AbbVie Inc.
GlaxoSmithKline plc
Olema Pharmaceuticals, Inc.
Scorpion Therapeutics, Inc.
Allorion Therapeutics Inc
Carrick Therapeutics Limited
Criterium, Inc.
Hoffmann-La Roche

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5995

Estrogen Blockers Market is estimated to be valued at USD 18.18 Bn in 2026 and is expected to reach USD 28.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 18.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.70%	2033 Value Projection:	USD 28.63 Bn

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

Global Estrogen Blockers Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Others
Global Estrogen Blockers Market, By Application (Revenue, USD Bn, 2021 - 2033)
Breast Cancer Treatment
Hormone Replacement Therapy (HRT)
Infertility Treatment
Post-Menopausal Osteoporosis
Others
Global Estrogen Blockers Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Global Estrogen Blockers Market, By Company:
Pfizer Inc.
Novartis AG
AstraZeneca PLC
Eli Lilly and Company
Merck & Co., Inc.
Bristol Myers Squibb Company
Sanofi S.A.
AbbVie Inc.
GlaxoSmithKline plc
Olema Pharmaceuticals, Inc.
Scorpion Therapeutics, Inc.
Allorion Therapeutics Inc
Carrick Therapeutics Limited
Criterium, Inc.
F.Hoffmann-La Roche

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Estrogen Blockers, By Product Type
- Market Estrogen Blockers, By Application
- Market Estrogen Blockers, By Distribution Channel
- Market Estrogen Blockers, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing Prevalence of Hormone-related Disorders
- Restraints
  - Side Effects and Safety Concerns
- Opportunities
  - Expansion of Indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Merger and Acquisition Scenario

4. Global Estrogen Blockers Market

Supply Side and Demand Side Analysis
Economic Impact

5. Global Estrogen Blockers Market , By Product Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Aromatase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Estrogen Receptor Downregulators (ERDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Estrogen Blockers Market , By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Breast Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Hormone Replacement Therapy (HRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Infertility Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Post-Menopausal Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Estrogen Blockers Market , By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Estrogen Blockers Market , By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Olema Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Scorpion Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Allorion Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Carrick Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Criterium, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

鹽酸Raloxifene昔芬市場－2026-2032年全球市場預測

選擇性雌激素受體分解藥(SERD)的全球市場 - 市場機會，學名藥的可得性，藥物用量，價格，臨床試驗趨勢(2030年)

FAQ

雌激素拮抗劑市場：依產品類型、應用、通路和地區分類